Logo image of SLNO

SOLENO THERAPEUTICS INC (SLNO) Stock Analyst Earnings Estimates

NASDAQ:SLNO - Nasdaq - US8342033094 - Common Stock - Currency: USD

85.25  -1.22 (-1.41%)

After market: 85.25 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Revenue
YoY % growth
SLNO revenue by date.SLNO revenue by date.
610K1.649M
-100.00%
271.32K49.33M299.32M
506.77%
590.1M
97.15%
EBITDA
YoY % growth
SLNO ebitda by date.SLNO ebitda by date.
-5.13M-12.05M
-134.89%
N/A
32.03%
N/A
-28.94%
N/A
-16.86%
N/A
-74.47%
N/A
-59.50%
N/A
13.89%
N/A
24.11%
N/A
-73.98%
N/A
-376.46%
N/AN/AN/A
EBIT
YoY % growth
SLNO ebit by date.SLNO ebit by date.
-5.16M-12.16M
-135.66%
-14.59M
31.58%
-10.821M
-46.27%
-18.473M
-17.50%
-23.829M
-64.27%
-37.078M
-54.49%
-36.973M
13.12%
-26.45M
22.61%
-37.192M
-68.03%
-180.712M
-358.54%
-150.31M
20.05%
44.872M
129.85%
302.61M
574.38%
Operating Margin
SLNO operating margin by date.SLNO operating margin by date.
N/A-1,993.44%-884.78%-3,988.35%N/AN/AN/AN/AN/AN/AN/A-304.70%14.99%51.28%
EPS
YoY % growth
SLNO eps by date.SLNO eps by date.
N/AN/A-82.62
56.28%
-18.21
67.27%
-14.99
38.30%
-10.20
13.97%
-6.83
48.84%
-6.66
11.36%
-3.50
43.25%
-2.52
10.54%
-4.31
-43.43%
-3.20
24.79%
1.24
138.64%
5.37
334.05%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.52
8.94%
-0.41
77.57%
-0.53
58.34%
-0.17
82.61%
-0.66
-27.73%
-0.63
-54.04%
-0.47
11.33%
Revenue
Q2Q % growth
22.698M33.841M30.192M45.053M6.528M
-71.24%
7.834M
-76.85%
15.902M
-47.33%
EBITDA
Q2Q % growth
N/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-23.158M
7.37%
-15.206M
80.99%
-25.981M
55.96%
-9.562M
79.21%
-28.531M
-23.20%
-27.673M
-81.98%
-20.524M
21.00%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2025
Q2Q % growth
-0.95
-61.02%
-0.950.00-0.42%
Q4 2024
Q2Q % growth
-1.27
-284.85%
-1.18-0.09-7.96%
Q3 2024
Q2Q % growth
-1.83
-92.63%
-0.64-1.19-186.49%
Q2 2024
Q2Q % growth
-0.57
29.63%
-0.610.046.60%
Q1 2024
Q2Q % growth
-0.59
32.95%
-0.38-0.21-57.04%
Q4 2023
Q2Q % growth
-0.33
43.10%
-0.28-0.05-18.37%
Q3 2023
Q2Q % growth
-0.95
-25.00%
-0.59-0.36-61.51%
Q2 2023
Q2Q % growth
-0.81
10.00%
-0.840.033.94%
Q1 2023
Q2Q % growth
-0.88
18.52%
-0.74-0.14-19.00%
Q4 2022
Q2Q % growth
-0.58
3.33%
-0.820.2428.92%
Q3 2022
Q2Q % growth
-0.76
49.33%
-0.930.1718.12%
Q2 2022
Q2Q % growth
-0.90
57.14%
-0.920.021.96%
Q1 2022
Q2Q % growth
-1.08
34.55%
-1.07-0.01-0.84%
Q4 2021
Q2Q % growth
-0.60 -1.300.7053.86%
Q3 2021
Q2Q % growth
-1.50
9.09%
-1.680.1810.87%
Q2 2021
Q2Q % growth
-2.10
12.50%
-1.63-0.47-28.67%
Q1 2021
Q2Q % growth
-1.65
15.38%
-1.17-0.48-40.66%
Q4 2020
Q2Q % growth
-0.60
88.89%
-1.070.4743.98%
Q3 2020
Q2Q % growth
-1.65
-466.67%
-1.33-0.32-24.43%
Q2 2020
Q2Q % growth
-2.40
48.39%
-3.140.7423.48%
Q1 2020
Q2Q % growth
-1.95
40.91%
-3.011.0635.20%
Q4 2019
Q2Q % growth
-5.40 -2.45-2.95-120.59%
Q3 2019
Q2Q % growth
0.45 -2.452.90118.38%
Q2 2019
Q2Q % growth
-4.65 -2.68-1.97-73.67%
Q1 2019
Q2Q % growth
-3.30 -4.441.1425.63%
SLNO Yearly EPS VS EstimatesSLNO Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -50 -100 -150
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
SLNO Yearly Revenue VS EstimatesSLNO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2025 2026 2027 100M 200M 300M 400M 500M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS44.94% 33.04% 2.62% -7.84%
Revenue490.33% 698.1% 3.1% 34.38%